Live feed
Filing
SC 13G
SC 13G0000929638-20-000622·TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 98943L107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-20-000622
- Form type
- SC 13G
- Filer
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD
- CIK
- CIK 1553936
- Filed
- May 29, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership